产品标题 产品货号 产品规格 厂家
Human RNA: Ovary; Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR5619865 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5601475 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5601755 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5602895 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5622105 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Adenocarcinoma of pancreas, ductal from ORIGENE TECHNOLOGIESCR5607815 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Adenocarcinoma of pancreas, metastatic from ORIGENE TECHNOLOGIESCR5601225 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Adenocarcinoma of pancreas, ductal from ORIGENE TECHNOLOGIESCR5601565 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Adenocarcinoma of pancreas, metastatic from ORIGENE TECHNOLOGIESCR5619165 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5622115 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Carcinoma of pancreas, anaplastic from ORIGENE TECHNOLOGIESCR5624935 ugORIGENE TECHNOLOGIES
Human RNA: Pancreas; Carcinoma of pancreas, acinar cell from ORIGENE TECHNOLOGIESCR5614775 ugORIGENE TECHNOLOGIES
PLCB1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31615010 ugORIGENE TECHNOLOGIES
PLCD4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4029351 kitORIGENE TECHNOLOGIES
PLCD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4082631 kitORIGENE TECHNOLOGIES
PLCD3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4091201 kitORIGENE TECHNOLOGIES
Plcd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134161 kitORIGENE TECHNOLOGIES
Plcd3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134171 kitORIGENE TECHNOLOGIES
PLCD4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30293510 ugORIGENE TECHNOLOGIES
PLCD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30826310 ugORIGENE TECHNOLOGIES
PLCE1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4132021 kitORIGENE TECHNOLOGIES
Plcd4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134181 kitORIGENE TECHNOLOGIES
Plce1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134191 kitORIGENE TECHNOLOGIES
PLCE1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31320210 ugORIGENE TECHNOLOGIES
PLCG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2163911 kitORIGENE TECHNOLOGIES
PLCG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN216391LP1 kitORIGENE TECHNOLOGIES
PLCG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN216391BN1 kitORIGENE TECHNOLOGIES
PLCG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN216391RB1 kitORIGENE TECHNOLOGIES
PLCG2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4004421 kitORIGENE TECHNOLOGIES
Plcg1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134201 kitORIGENE TECHNOLOGIES
Plcg2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134211 kitORIGENE TECHNOLOGIES
PLCG1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31644810 ugORIGENE TECHNOLOGIES
PLCG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4163911 kitORIGENE TECHNOLOGIES
PLCH1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4106861 kitORIGENE TECHNOLOGIES
PLCG2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30044210 ugORIGENE TECHNOLOGIES
PLCH2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4118821 kitORIGENE TECHNOLOGIES
Plch1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5134221 kitORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS7115815x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS7115825x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS5320605x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS5449355x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous (protein lysate) from ORIGENE TECHNOLOGIESCP815065150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP529617150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIESCS5372965x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP531866150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP531533150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP537436150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP542781150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP541360150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal (protein lysate) from ORIGENE TECHNOLOGIESCP544778150 ugORIGENE TECHNOLOGIES
 |< < 1288 1289 1290 1291 1292 1293 1294 1295 1296 > >| 第 1295/6274 页